Study Finds Novavax COVID-19 Vaccine 90 Percent Effective

Doctor preparing COVID-19 Vaccine

Novavax announced on Monday that its two-dose COVID-19 vaccine is 90% effective, according to a press release on Novavax’s website.

The phase-3 trial enrolled 29,960 participants ages 18 and older in the U.S. and Mexico. The study found that 77 of the participants tested positive for COVID-19, with 63 testing positive in the placebo group and 14 in the vaccine group, according to the press release.

“Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines. These clinical results reinforce that NVX-CoV2373 is extremely effective and offers complete protection against both moderate and severe COVID-19 infection,” Stanley C. Erck, President, and CEO of Novavax said in the press release.

Read More

Commentary: The Left Uses Junk Studies to Show Racism

On March 23, 1989, a room full of reporters and scientists was buzzing in anticipation of an announcement of a breakthrough that, if it panned out, would propel humanity into a new era of unlimited pollution-free energy. The University of Utah’s vice president for research introduced two scientists, Dr. Stan Pons, and Dr. Martin Fleishman. The scientists then announced that a simple device using palladium and heavy water could generate energy from a type of cold fusion resulting from chemical reactions.

Read More